The Pfizer company said Wednesday that its experimental test for the COVID-19 vaccine is 95% effective based on final results and shows signs of being safe. It is preparing to ask regulators for authorization to use it.
Pfizer’s plan, as published by the New York Times, is to request authorization for the vaccine in days, which would leave it on track to begin shipping by the end of the year if regulators allow it.
The expectation in terms of production will reach 50 million doses this year and 1.3 billion in 2021.
The report prompted the markets throughout the world and also dollar.
.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
